Elanco Animal Health Incorporated (ELAN)

Elanco Animal Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	4,715	4,439	4,417	4,411	4,764
Revenue Growth (YoY)	6.22%	0.50%	0.14%	-7.41%	45.64%
Cost of Revenue	2,122	2,003	1,931	1,913	2,132
Gross Profit	2,593	2,436	2,486	2,498	2,632
Selling, General & Admin	1,430	1,314	1,285	1,265	1,403
Depreciation & Amortization Expenses	543	527	548	528	556
Research & Development	368	344	327	321	369
Other Operating Expenses	256	168	1,244	215	639
Total Operating Expenses	2,597	2,353	3,404	2,329	2,967
Operating Income	-4	83	-918	169	-335
Interest Expense	-220	-235	-277	-241	-236
Other Non-Operating Income (Expense)	-	640	-	-	-
Total Non-Operating Income (Expense)	-220	405	-277	-241	-236
Pretax Income	-224	488	-1,195	-72	-571
Provision for Income Taxes	8	150	36	6	-88
Net Income	-232	338	-1,231	-78	-483
Net Income to Common	-232	338	-1,231	-78	-483
Shares Outstanding (Basic)	496	494	492	488	487
Shares Outstanding (Diluted)	496	497	492	488	487
Shares Change (YoY)	-0.18%	1.02%	0.82%	0.23%	10.38%
EPS (Basic)	-0.47	0.68	-2.50	-0.16	-0.99
EPS (Diluted)	-0.47	0.68	-2.50	-0.16	-0.99
Free Cash Flow	284	394	131	281	324
Free Cash Flow Growth	-27.92%	200.76%	-53.38%	-13.27%	-
Free Cash Flow Per Share	0.57	0.79	0.27	0.58	0.67
Gross Margin	54.99%	54.88%	56.28%	56.63%	55.25%
Operating Margin	-0.08%	1.87%	-20.78%	3.83%	-7.03%
Profit Margin	-4.92%	7.61%	-27.87%	-1.77%	-10.14%
FCF Margin	6.02%	8.88%	2.97%	6.37%	6.80%
EBITDA	676	745	-224	851	381
EBITDA Margin	14.34%	16.78%	-5.07%	19.29%	8.00%
EBIT	-4	83	-918	169	-335
EBIT Margin	-0.08%	1.87%	-20.78%	3.83%	-7.03%
Effective Tax Rate	-3.57%	30.74%	-3.01%	-8.33%	15.41%

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q